Glucose metabolism reprogramming in gynecologic malignant tumors

J Cancer. 2024 Mar 17;15(9):2627-2645. doi: 10.7150/jca.91131. eCollection 2024.

Abstract

The incidence and mortality of gynecological tumors are progressively increasing due to factors such as obesity, viral infection, unhealthy habits, as well as social and economic pressures. Consequently, it has emerged as a significant threat to women's health. Numerous studies have revealed the remarkable metabolic activity of tumor cells in glycolysis and its ability to influence malignant biological behavior through specific mechanisms. Therefore, it is crucial for patients and gynecologists to comprehend the role of glycolytic proteins, regulatory molecules, and signaling pathways in tumorigenesis, progression, and treatment. This article aims to review the correlation between abnormal glucose metabolism and gynecologic tumors including cervical cancer (CC), endometrial carcinoma (EC), and ovarian cancer (OC). The findings from this research will provide valuable scientific insights for early screening, timely diagnosis and treatment interventions while also aiding in the prevention of recurrence among individuals with gynecological tumors.

Keywords: Warburg effect; aerobic glycolysis; cervical cancer; endometrial carcinoma; ovarian cancer; pathological mechanism.

Publication types

  • Review